TickerFacts.

EUDA Health Holdings Ltd (EUDA): R&D Expense

Annual figures by period end, from SEC filings.

$249
Year ended 2025-12-31
-75.6%
3-year compound annual growth
$129.3K2021-12-31: $129.3K2022-12-31: $17.2K2025-12-31: $249$249
2021-12-31 R&D Expense (USD) 2025-12-31
Period endedR&D ExpenseChange YoYSource filing
2025-12-31$249n/a2026-04-28, From 2025-01-01
No annual figure between 2022-12-31 and 2025-12-31.
2022-12-31$17.2K-86.7%2023-06-28, From 2022-01-01
2021-12-31$129.3Kn/a2023-06-28, From 2021-01-01

R&D Expense at similar companies

Companies with the same SEC industry code (Services-Health Services), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedR&D ExpenseChange YoY
EUDA Health Holdings Ltd (EUDA)2025-12-31$249n/a
Omada Health, Inc. (OMDA)2025-12-31$40.68M+13.3%
DocGo Inc. (DCGO)2025-12-31$13.56M+17.0%
GeneDx Holdings Corp. (WGS)2025-12-31$72.03M+57.5%

Compare EUDA, OMDA, DCGO, WGS side by side · Screen every company in Services-Health Services ↗